Author:
Shi Lu,Hu Jinyu,Wu Hualu,Shen Yuxin,Chen Xiaohai,Weng Qinghua,Xu Ren-ai,Tang Congrong
Reference25 articles.
1. Iguratimod as a new drug for rheumatoid arthritis: current landscape;Xie;Front. Pharmacol.,2020
2. The effect and safety of iguratimod combined with methotrexate on rheumatoid arthritis: a systematic review and meta-analysis based on a randomized controlled trial;Zeng;Front Pharm.,2021
3. Efficacy and safety of iguratimod on patients with primary Sjögren's syndrome: a randomized, placebo-controlled clinical trial;Shao;Scand. J. Rheumatol.,2021
4. Iguratimod treatment reduces disease activity in early primary Sjögren's syndrome: an open-label pilot study;Chen;Mod. Rheumatol.,2021
5. Efficacy and safety of iguratimod combined with methylprednisolone for primary Sjogren's syndrome: a meta-analysis and trial sequential analysis;Hu;Eur. Rev. Med Pharm. Sci.,2023